{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:56:29Z","timestamp":1761764189703},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.lfs.2003.07.019","type":"journal-article","created":{"date-parts":[[2003,11,15]],"date-time":"2003-11-15T12:00:40Z","timestamp":1068897640000},"page":"843-853","source":"Crossref","is-referenced-by-count":59,"title":["Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells"],"prefix":"10.1016","volume":"74","author":[{"given":"Seiji","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lfs.2003.07.019_BIB1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"British Journal of Urology"},{"issue":"1","key":"10.1016\/j.lfs.2003.07.019_BIB2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/10454411000110010301","article-title":"Regulation of calcium in salivary gland secretion","volume":"11","author":"Ambudkar","year":"2000","journal-title":"Critical Reviews in Oral Biology and Medicine"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2003.07.019_BIB3","first-page":"82","article-title":"Pharmacokinetics and bioequivalence of darifenacin, a new, selective M3 muscarinic antagonist","volume":"89","author":"Bohm","year":"2001","journal-title":"Pharmacology and Toxicology"},{"issue":"2","key":"10.1016\/j.lfs.2003.07.019_BIB4","first-page":"279","article-title":"International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacological Reviews"},{"issue":"5A Suppl.","key":"10.1016\/j.lfs.2003.07.019_BIB5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0090-4295(99)00492-6","article-title":"Muscarinic receptor antagonists in the treatment of overactive bladder","volume":"55","author":"Chapple","year":"2000","journal-title":"Urology"},{"issue":"23","key":"10.1016\/j.lfs.2003.07.019_BIB6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of an inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochemical Pharmacology"},{"issue":"6 Pt 1","key":"10.1016\/j.lfs.2003.07.019_BIB7","doi-asserted-by":"crossref","first-page":"C1063","DOI":"10.1152\/ajpcell.1991.261.6.C1063","article-title":"Evidence that M3 muscarinic receptors in rat parotid gland couple to two second messenger systems","volume":"261","author":"Dai","year":"1991","journal-title":"American Journal of Physiology"},{"issue":"2","key":"10.1016\/j.lfs.2003.07.019_BIB8","first-page":"E97","article-title":"Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves","volume":"235","author":"DeLean","year":"1978","journal-title":"American Journal of Physiology"},{"issue":"1","key":"10.1016\/j.lfs.2003.07.019_BIB9","first-page":"257","article-title":"Selectivity of muscarinic antagonists in radioligand and in vivo experiments for the putative M1, M2 and M3 receptors","volume":"242","author":"Doods","year":"1987","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.019_BIB10","first-page":"531","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"Eglen","year":"1996","journal-title":"Pharmacological Reviews"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.019_BIB11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0165-6147(94)90047-7","article-title":"Muscarinic acetylcholine receptor subtypes in smooth muscle","volume":"15","author":"Eglen","year":"1994","journal-title":"Trends in Pharmacological Sciences"},{"issue":"18","key":"10.1016\/j.lfs.2003.07.019_BIB12","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0024-3205(97)00433-5","article-title":"Subtypes of the muscarinic receptor in smooth muscle","volume":"61","author":"Ehlert","year":"1997","journal-title":"Life Sciences"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.019_BIB13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2165\/00002512-199303040-00004","article-title":"The problems of anticholinergic adverse effects in older patients","volume":"3","author":"Feinberg","year":"1993","journal-title":"Drugs and Aging"},{"issue":"8","key":"10.1016\/j.lfs.2003.07.019_BIB14","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1096\/fasebj.9.8.7768353","article-title":"Muscarinic acetylcholine receptors: signal transduction through multiple effectors","volume":"9","author":"Felder","year":"1995","journal-title":"FASEB Journal"},{"issue":"2-3","key":"10.1016\/j.lfs.2003.07.019_BIB15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0014-2999(98)00214-3","article-title":"Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists","volume":"349","author":"Gillberg","year":"1998","journal-title":"European Journal of Pharmacology"},{"issue":"19","key":"10.1016\/j.lfs.2003.07.019_BIB16","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/0024-3205(88)90398-0","article-title":"Characterization of muscarinic receptor subtypes in human tissues","volume":"43","author":"Giraldo","year":"1988","journal-title":"Life Sciences"},{"key":"10.1016\/j.lfs.2003.07.019_BIB17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1146\/annurev.pa.30.040190.003221","article-title":"Muscarinic receptor subtypes","volume":"30","author":"Hulme","year":"1990","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"2","key":"10.1016\/j.lfs.2003.07.019_BIB18","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00210-002-0554-x","article-title":"M3 receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland","volume":"366","author":"Ikeda","year":"2002","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"issue":"15","key":"10.1016\/j.lfs.2003.07.019_BIB19","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0024-3205(99)00402-6","article-title":"Ca2+ mobilization and activation of extracellular acidification by carbachol in acutely dispersed cells from guinea pig detrusor: Fura 2 fluorometry and microphysiometry using the Cytosensor","volume":"65","author":"Ikeda","year":"1999","journal-title":"Life Sciences"},{"issue":"3","key":"10.1016\/j.lfs.2003.07.019_BIB20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1056-8719(01)00149-6","article-title":"A method for measurement of muscarinic receptor-mediated responses in dissociated single colon longitudinal smooth muscle cells","volume":"45","author":"Kobayashi","year":"2001","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"3","key":"10.1016\/j.lfs.2003.07.019_BIB21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1254\/jjp.86.281","article-title":"Effects of YM905, a novel muscarinic M3-receptor antagonist, on experimental models of bowel dysfunction in vivo","volume":"86","author":"Kobayashi","year":"2001","journal-title":"Japanese Journal of Pharmacology"},{"issue":"4","key":"10.1016\/j.lfs.2003.07.019_BIB22","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1111\/j.1476-5381.1993.tb13737.x","article-title":"Estimation of competitive antagonist affinity from functional inhibition curves using the Gaddum, Schild and Cheng-Prusoff equation","volume":"109","author":"Lazareno","year":"1993","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2003.07.019_BIB23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-6147(93)90018-F","article-title":"Estimation of antagonist Kb from inhibition curves in functional experiments: alternatives to the Cheng-Prusoff equation","volume":"14","author":"Lazareno","year":"1993","journal-title":"Trends in Pharmacological Sciences"},{"issue":"2-3","key":"10.1016\/j.lfs.2003.07.019_BIB24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0922-4106(90)90052-Y","article-title":"Muscarinic M3 receptors are coupled to two signal transduction pathways in rat submandibular cells","volume":"188","author":"Laniyonu","year":"1990","journal-title":"European Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.lfs.2003.07.019_BIB25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0022-5347(05)66326-4","article-title":"Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial","volume":"165","author":"Malone-Lee","year":"2001","journal-title":"Journal of Urology"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2003.07.019_BIB26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/10454411940050030401","article-title":"Developmental aspects of fluid and electrolyte secretion in salivary glands","volume":"5","author":"Martinez","year":"1994","journal-title":"Critical Reviews in Oral Biology and Medicine"},{"issue":"17","key":"10.1016\/j.lfs.2003.07.019_BIB27","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"10","key":"10.1016\/j.lfs.2003.07.019_BIB28","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1242\/jcs.115.10.2207","article-title":"Agonist-induced phasic and tonic responses in smooth muscle are mediated by InsP3","volume":"115","author":"McCarron","year":"2002","journal-title":"Journal of Cell Science"},{"issue":"2\u20133","key":"10.1016\/j.lfs.2003.07.019_BIB29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine-a new bladder-selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"European Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.lfs.2003.07.019_BIB30","doi-asserted-by":"crossref","first-page":"C1666","DOI":"10.1152\/ajpcell.1994.267.6.C1666","article-title":"Sources of calcium utilized in cholinergic responses in canine colonic smooth muscle","volume":"267","author":"Sato","year":"1994","journal-title":"American Journal of Physiology"},{"issue":"Suppl.","key":"10.1016\/j.lfs.2003.07.019_BIB31","first-page":"205P","article-title":"The effects of darifenacin and oxybutynin on bladder function and salivation in the conscious rat","volume":"120","author":"Williamson","year":"1997","journal-title":"British Journal of Pharmacology (Proc.)"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320503009640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320503009640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T23:29:26Z","timestamp":1623540566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320503009640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0024320503009640"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2003.07.019","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}